Skip to main content
Premium Trial:

Request an Annual Quote

BioSolutions, Bioquote Reach Distribution Deal for UK, Ireland

NEW YORK (GenomeWeb News) – Claremont BioSolutions today announced a distribution deal with Bioquote covering the UK and Ireland.

The deal is for Claremont's products for sample preparation, DNA isolation, and protein purification and extends the Upland, Calif.-based company's reach into Europe. The first product to be marketed will be the company's Omnilyse lysis kits and PureLyse extraction kits.

Claremont develops, manufactures, and markets cell lysis, DNA extraction, and His-tagged protein purification kits and columns. Bioquote, headquartered in York, UK, distributes life science products throughout Europe.

Financial and other terms of the deal were not disclosed.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.